TT 62

Drug Profile

TT 62

Alternative Names: TEI 6170

Latest Information Update: 19 Oct 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Teijin Pharma
  • Class Antineoplastics
  • Mechanism of Action Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Breast cancer; Gastrointestinal cancer; Lung cancer

Most Recent Events

  • 19 Oct 2000 Discontinued-II for Breast cancer in Japan (Unknown route)
  • 19 Oct 2000 Discontinued-II for Gastrointestinal cancer in Japan (Unknown route)
  • 19 Oct 2000 Discontinued-II for Lung cancer in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top